[Other] Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2− advanced breast cancer: a real-world evidence cohort |
|
This post will be closed automatically in 2026-07-21 02:05
Reward20points
|
post
reply
points
1400
30
Salmon nasal cartilage-derived proteoglycan complexes influence the gutmicrobiota and bacterial metabolites in mice
30
Differential diagnosis of appendicitis and pelvic inflammatory disease
20
Expanding Technology-Enabled, Nurse-Delivered Chronic Disease Care
20
Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline
100
Coronary artery calcium in athletes: friend or foe?